Literature DB >> 2832795

The predominance of human papillomavirus type 16 in vulvar neoplasia.

J Buscema1, Z Naghashfar, E Sawada, R Daniel, J D Woodruff, K Shah.   

Abstract

Southern transfer analysis for human papillomavirus genomic sequences was conducted on 152 vulvar and vaginal tissue specimens obtained from 86 patients. Histopathologic diagnoses included condyloma acuminatum, intraepithelial neoplasia, and invasive cancer. In six patients, lesions of more than one pathologic type were identified. Vaginal lesions constituted less than 5% of tissues examined. Distribution of lesions was as follows: condyloma, 93 lesions from 57 patients; intraepithelial neoplasia, 47 lesions from 29 patients; and invasive carcinoma, 12 lesions from six patients. Seventy-five percent of the patients were white. The mean age of the patients increased from 25 years for condyloma to 38 years for vulvar intraepithelial neoplasia III to 56 years for invasive cancer. A viral diagnosis was made in 81% of condylomas, 84% of vulvar intraepithelial neoplasia III, and 58% of invasive carcinomas. Distribution of viral types differed markedly for the various histopathologies. Types 6/11 accounted for 77% of condylomas and 0% of vulvar intraepithelial neoplasia III. Type 16 was recovered from 12% of condylomas and 81% of vulvar intraepithelial neoplasia III. Type 18 was identified in a small proportion in both categories; type 31 was seen in a few vulvar intraepithelial neoplasia III lesions. In invasive carcinomas, type 16 was the predominantly identified virus. Papillomavirus type 16 emerges as the dominant oncogenic virus in vulvar neoplasms. Its presence in a large percentage of condylomas raises the issue of an "atypical condyloma" as a precursor of neoplasia.

Entities:  

Mesh:

Year:  1988        PMID: 2832795

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Coexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients.

Authors:  Kruti P Maniar; Brigitte M Ronnett; Russell Vang; Anna Yemelyanova
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

2.  Human papilloma virus infections.

Authors:  V C Wright
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

3.  Occurrence of multiple types of human papillomavirus in genital tract lesions. Analysis by in situ hybridization and the polymerase chain reaction.

Authors:  G J Nuovo; M M Darfler; C C Impraim; S E Bromley
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

4.  An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.

Authors:  A E Rice; Y E Latchman; J P Balint; J H Lee; E S Gabitzsch; F R Jones
Journal:  Cancer Gene Ther       Date:  2015-09-04       Impact factor: 5.987

5.  Dual genitotropic human papillomavirus infections in genital warts.

Authors:  J Aznar; A Ojeda; M J Torres; J C Palomares; A Rodriguez-Pichardo
Journal:  Genitourin Med       Date:  1993-02

Review 6.  Squamous precursor lesions of the vulva: current classification and diagnostic challenges.

Authors:  Lien N Hoang; Kay J Park; Robert A Soslow; Rajmohan Murali
Journal:  Pathology       Date:  2016-04-23       Impact factor: 5.306

7.  Photodynamic therapy for gynecological diseases and breast cancer.

Authors:  Natashis Shishkova; Olga Kuznetsova; Temirbolat Berezov
Journal:  Cancer Biol Med       Date:  2012-03       Impact factor: 4.248

8.  Human papillomavirus in vulvar and vaginal carcinoma cell lines.

Authors:  S Hietanen; S Grénman; K Syrjänen; K Lappalainen; J Kauppinen; T Carey; S Syrjänen
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.